Fipamezole is a α2-adrenoceptor antagonist potentially for the treatment of dyskinesia associated with Parkinson's disease. References: Pilleri M, Antonini A. Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease. Expert Opin Drug Saf. 2015 Feb;14(2):281-94. doi: 10.1517/14740338.2015.988137. Epub 2014 Dec 6. Review. PubMed PMID: 25483147.

纯度：≥98%

CAS：150586-58-6